Achaogen's IPO

Achaogen raised a round of funding on March 12, 2014. Investors include Public.

Achaogen specializes in the discovery and development of small molecules to treat infections caused by bacterial infection, and by antibiotic-resistant strains in particular. Achaogen focuses on high …

Articles about Achaogen's IPO: